Clinical Trials · NCT01542242

Liraglutide Use in Prader-Willi Syndrome

Name: Liraglutide Use in Prader-Willi Syndrome
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

TerminatedPhase 4Liraglutide

Phase: Phase 4
Recruitment status: Terminated
Sponsor: Vancouver General Hospital
Enrollment: 1
Start date: Feb 2012
Locations: 1 site, Canada
Primary endpoint: Hemoglobin A1C

View Liraglutide compound reference